References

zdor

Проблемы здоровья и экологии

Health and Ecology Issues

2220-09672708-6011

Gomel State Medical University

10.51523/2708-6011.2012-9-3-3

zdor-1274

Research Article

ОБЗОРЫ И ЛЕКЦИИ

REVIEWS AND LECTURES

МОРФОЛОГИЧЕСКИЕ ОСОБЕННОСТИ КОСТНОГО МОЗГА У ПАЦИЕНТОВ С МИЕЛОДИСПЛАСТИЧЕСКИМ СИНДРОМОМ (обзор литературы)

MORPHOLOGICAL FEATURES OF BONE MARROW IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (literature review)

Жандаров

М. Ю.

Zhandarov

M. U.

noemail@neicon.ru

Гомельский государственный медицинский университетGomel State Medical University

2012

28092012

031418

2012

Жандаров М.Ю.

Zhandarov M.U.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://journal.gsmu.by/jour/article/view/1274

Цель исследования: оценка возможности гистологической диагностики материала костного мозга при миелодиспластических синдромах. Материал исследования: аналитический обзор публикаций. Результаты: определены возможности метода. Заключение. Морфологические изменения в костном мозге при миелодиспластическом синдроме не являются строго специфичными и должны оцениваться в совокупности с клиническими и другими лабораторными методами.

The aim of research: to assess the possibility of histological diagnosis of bone marrow sample in myelodysplastic syndrome. Materials: analytical review of publications. Results: the possibilities of the method application were determined. Conclusion. Morphological changes in bone marrow in myelodysplastic syndromes are not strictly specific and should be evaluated taking into consideration other clinical and laboratory methods.

красный костный мозгмиелодиспластический синдромгистологическое исследованиеred bone marrowmyelodysplastic syndromehistologic research

References1

Ayalew Tefferi, M. D. Myelodysplastic Syndromes / M. D. Ayalew Tefferi, W. James, M. D. Vardiman // The New England Journal of Medicine - 2009. - № 361. - Р. 1872-1885.

Rollison, D. E. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States / D. E. Rollison, N. Howlader, M. T. Smith // Blood - 2008. - № 112. - Р. 45-52.

Абдулкадыров, К. М. Гематология: Новейший справочник / К. М. Абдулкадыров. - М.: Эксмо, 2004. - 927 c.

Myelodysplastic syndromes / W. K. Hofmann [et al.] // Hematology - 2004. - № 5. - Р. 1-8.

Myelodysplastic syndrome / G. Mufti [et al.] // Hematology. - 2003. - № 3. - Р. 176-199.

Nimer, S. D. Myelodysplastic syndromes / S. D. Nimer // Blood. - 2008. - № 111. - Р. 4841-4851.

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes / U. Germing [et al.] // Ann Hematol. - 2008. - № 87. - Р. 691-699.

Vardiman, J. W. The 2008 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia: rationale and important changes / J. W. Vardiman, J. Thiele, D. A. Arber // Blood. - 2009. - № 114. - Р. 937-951.

Alter, B. P. Diagnosis, genetics, and management of inherited bone marrow failure syndromes / B. P. Alter // Hematology (Am Soc Hematol Educ Program). - 2007. - Р. 29-39.

Шиффман, Ф. Дж. Патофизиология крови / Ф. Дж. Шиффман. - М.: БИНОМ, 2000. - С. 347-349.

Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes / N. S. Fracchiolla [et al.] // Haematologica. - 2003. - № 88. - Р. 594-597.

Mufti, G. J. Pathobiology, classification, and diagnosis of myelodysplastic syndrome / G. J. Mufti // Best Pract Res Clin Haematol. - 2004. - № 17. - С. 543-557.

Valent, P. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions / P. Valent, H. P. Horny // Eur J Clin Invest. - 2009. - № 39. - Р. 548-553.

Lopez-Villar, O. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome / O. Lopez-Villar, J. L. Garcia, F. M. Sanchez-Guijo // Leukemia - 2009. - № 23. - Р. 664-672.

Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization / E. Flores-Figueroa [et al.] // Leuk Res. - 2005. - № 29. - Р. 215-224.

Horny, H. P. Diagnostic value of histology and immuno-histochemistry in myelodysplastic syndromes / H. P. Horny, K. Soltar, P. Valent // Leuk Res. - 2007. - № 31. - Р. 1609-1616.

Della Porta, M. G. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes / M. G. Della Porta, L. Malcovati, G. M. Rigolin // Leukemia. - 2008. - № 22. - Р. 530-537.

Mohamedali, A. Van-den Berghe’s 5q-syndrome / A. Mohamedali, G. J. Mufti // Br J Haematol. - 2009. - № 144. - Р. 157-168.

Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia or myelodysplastic syndrome / A. K. Wong [et al.] // Arch Pathol Lab Med. - 2008. - № 132. - Р. 1329-1332.

Pozdnyakova, O. Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities / O. Pozdnyakova, P. M. Miron, G. Tang // Cancer. - 2008. - № 113. - Р. 3331-3340.

Komrokji, R. S. Evolving classifications of the myelodysplastic syndromes / R. S. Komrokji, J. M. Bennett // Curr Opin Hematol. - 2007. - № 14. - Р. 98-105.

Greenberg, P. International scoring system for evaluating prognosis in myelodysplastic syndromes / P. Greenberg, C. Cox, M. M. LeBeau // Blood. - 1997. - № 89. - Р. 2079-2088.

Mills, K. I. Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome / K. I. Mills, A. Kohlmann, P. M. Williams // Blood. - 2009. - № 114. - Р. 1063-1072.

Garcia-Manero, G. A prognostic score for patients with lower risk myelodysplastic syndrome / G. Garcia-Manero, J. Shan, S. Faderl // Leukemia. - 2008. - № 22. - Р. 538-543.

Verburgh, E. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification / E. Verburgh, R. Achten, V. J. Louw // Leukemia. - 2007. - № 21. - Р. 668-677.

Germing, U. Refinement of the Intenational Prognostic Scoring System (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes / U. Germing, B. Hildebrandt, M. Pfeilstöcker // Leukemia. - 2005. - № 19. - Р. 2223-2231.

Time dependent prognostic scoring system for predicting survival and leukemic evolution in the myelodysplastic syndromes / L. Malcovati [et al.] // Clinical Oncology. - 2007. - № 25. - Р. 3503-3510.

Sanz, G. F. Prognostic factors and scoring systems in myelodysplastic syndromes / G. F. Sanz, M. A. Sanz, P. L. Greenberg // Haematologica. - 1998. - № 83. - Р. 358-368.

Prognostic implication and characterization of the blast cell population in the myelodysplastic syndrome / J. E. Goasguen [et al.] // Leuk Res - 1991. - № 15. - Р. 1159-1165.

The authors declare that there are no conflicts of interest present.